William Fitzsimmons

Adjunct Professor

University of Illinois Chicago College of Pharmacy

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

William Fitzsimmons is an Adjunct Professor at the University of Illinois Chicago College of Pharmacy, United States. His research areas encompass organ transplantation, clinical trial diversity, and immunosuppressive therapy needs, based on his recent publications. He has contributed significantly to understanding long-term kidney graft survival and the impact of COVID-19 on vulnerable populations in the context of drug development.

Articles (8)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Collaborators (5)

David Taber

UNITED STATES

View details

Elisa Gordon

Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Allison Tong

University of Sydney

AUSTRALIA

View details

Mark Stegall

Professor of Surgery

Mayo Clinic

UNITED STATES

View details

Roslyn Mannon

University of Nebraska Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

William Fitzsimmons

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Therapeutic needs in solid organ transplant recipients: The American Society of Transplantation patient survey

Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival

Applying propensity methods to the United States transplant registry for external real-world evidence control arms for 5-year survival in the BENEFIT study

Quantifying Clinical Trial Diversity in Pivotal Registration Trials of FDA Novel Drug Approvals

A viewpoint describing the American Society of Transplantation rationale to conduct a comprehensive patient survey assessing unmet immunosuppressive therapy needs

Longitudinal estimated glomerular filtration rate (eGFR) modeling in long‐term renal function to inform clinical trial design in kidney transplantation

COVID-19 vaccine associated transverse myelitis-Evusheld as an option when vaccination is not recommended due to severe adverse events

Ensuring Black Lives Matter in Drug Development.

Collaborators (5)

David Taber

Elisa Gordon

Allison Tong

Mark Stegall

Roslyn Mannon

Make your next move.